Edesa Biotech Inc
EDSA
NASDAQ
Biotechnology
$5.35
USD
-0.08 (-1.47%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $51.92M
Volume 45.9K
Revenue
$0
TTM
— YoY
Gross Margin
—
TTM
— YoY
Net Income
$-10.44M
TTM
-78.9%
YoY
Operating Cash Flow
$-7.53M
TTM
-31.5%
YoY
Revenue & Net Income
USD Millions
Margins Trend
Percent of revenue
Income Statement Detail
USD Millions, except per-share and share count figures
Metric | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|---|
Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
YoY Growth | — | — | — | — | — |
Cost of Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Gross Profit | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Selling, General & Administrative | 1.2 | 1.0 | 1.2 | 1.2 | 1.5 |
Other Operating Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Total Operating Expenses | 1.6 | 1.9 | 2.5 | 2.3 | 4.3 |
Operating Income | -1.6 | -1.9 | -2.5 | -2.3 | -4.3 |
EBITDA | -1.6 | -1.9 | -2.4 | -2.3 | -4.3 |
Other Income / Expense | 0.0 | 0.2 | 0.2 | 0.1 | 0.1 |
Total Other Income / Expense | 0.0 | 0.2 | 0.2 | 0.1 | 0.1 |
Income Before Income Taxes | -1.6 | -1.7 | -2.2 | -2.2 | -4.2 |
Income Taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Net Income | -1.6 | -1.7 | -2.2 | -2.2 | -4.2 |
Consolidated Net Income / Loss | -1.6 | -1.7 | -2.2 | -2.2 | -4.2 |
Net Income Attributable to Common Shareholders | -1.6 | -1.7 | -2.2 | -2.2 | -4.2 |
Basic EPS | -$0.30 | -$0.25 | -$0.32 | -$0.28 | -$0.49 |
Diluted EPS | -$0.30 | -$0.25 | -$0.32 | -$0.28 | -$0.49 |
Basic Shares Outstanding | 5.3M | 7.0M | 7.0M | 8.0M | 8.5M |
Diluted Shares Outstanding | 5.3M | 7.0M | 7.0M | 8.0M | 8.5M |